AVITA Medical (ASX:AVH) Moat Score: 4/10 (As of Jun. 29, 2026)


ASX:AVH AVITA Medical Inc ASX:AVH
53 GF Score
Price A$1.09
GF Value A$2.92
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical Moat Score?

AVITA Medical ASX:AVH -2.25% 53 Moat Score is 4 as of Jun. 29, 2026. GuruFocus rates ASX:AVH with a GF Score™ of 53/100 and a GF Value™ of A$2.92 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 847 Medical Devices & Instruments companies, AVITA Medical ranks better than 83.23% on this metric.

AVITA Medical has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

AVITA Medical has Narrow Moat: AVITA Medical Inc has some valuable intellectual property in the medical field, providing modest competitive advantages. However, it lacks strong brand strength and significant market share, limiting its overall moat to a discernible but modest level.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes AVITA Medical might have Narrow Moat - Discernible but modest moat.

AVITA Medical  (ASX:AVH) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

AVITA Medical Moat Score Related Terms

ASX:AVH vs MXCT, HYPR, ZOMDF: Moat Score Comparison

For the Medical Devices subindustry, AVITA Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVITA Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Moat Score falls into.


ASX:AVH
53GF Score
AVITA Medical Inc ASX:AVH
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
AVITA Medical (ASX:AVH) has a Moat Score of 4 as of Jun. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, AVITA Medical ranks #142 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 16.8%.
Is AVITA Medical's Moat Score too high?
AVITA Medical's current Moat Score is 4. Based on the distribution chart, AVITA Medical ranks #142 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AVITA Medical has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's Moat Score compare to MXCT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #142 out of 847 companies for Moat Score. This places AVITA Medical in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. AVITA Medical's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (ASX:AVH) is currently considered Possible Value Trap. The stock's GF Value™ is A$2.92, compared to a current price of A$1.09 — trading 62.8% below its estimated fair value. The current Moat Score is 4. AVITA Medical's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For AVITA Medical (ASX:AVH), the current Moat Score is 4 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AVITA Medical (ASX:AVH) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of A$1.09 is trading 62.8% below its estimated GF Value™ of A$2.92. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for ASX:AVH:

  • Moat Score: 4
  • GF Value™: A$2.92 vs. price of A$1.09 (62.8% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
53GF Score

Get the complete analysis for ASX:AVH

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.09
Price
A$2.92
GF Value